StonvexLoading…
StonvexStonvexStonvexCore line items from TCRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $982.00K | $10.32M | $7.76M | $5.25M |
Operating Income | $-29.14M | $-135.81M | $-111.95M | $-74.90M |
Net Income | $-28.67M | $-129.77M | $-106.79M | $-71.08M |
EPS (Diluted) | $-0.22 | $-1.00 | $-0.82 | $-0.55 |
Total Assets | $201.99M | $228.79M | $262.23M | $298.56M |
Total Liabilities | $105.07M | $105.67M | $118.20M | $121.85M |
Cash & Equivalents | $128.06M | $152.41M | $169.51M | $169.39M |
Free Cash Flow OCF − CapEx | $-24.35M | $-139.73M | $-107.55M | $-73.66M |
Shares Outstanding | 129.91M | 129.78M | 129.75M | 129.70M |